Phosphodiesterase-3 Inhibitor Enoximone in SARS-CoV-2 Infection. | J Aerosol Med Pulm Drug Deliv;34(5): 322-323, 2021 09. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Phosphodiesterase-3 Inhibitor Enoximone in SARS-CoV-2 Infection.

Beute, Jan; KleinJan, Alex.

Beute J; Intensive Care, Tjongerschans, Heerenveen, The Netherlands.
KleinJan A; Erasmus MC, Rotterdam, The Netherlands.

J Aerosol Med Pulm Drug Deliv ; 34(5): 322-323, 2021 09.

Article in English | MEDLINE | ID: covidwho-1411828

Subject(s)

COVID-19; Enoximone; Administration, Inhalation; Humans; Phosphoric Diester Hydrolases; SARS-CoV-2

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Enoximone / COVID-19 Limits: Humans Language: English Journal: J Aerosol Med Pulm Drug Deliv Journal subject: Drug Therapy Year: 2021 Document Type: Article Affiliation country: JAMP.2021.0042

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Enoximone / COVID-19 Limits: Humans Language: English Journal: J Aerosol Med Pulm Drug Deliv Journal subject: Drug Therapy Year: 2021 Document Type: Article Affiliation country: JAMP.2021.0042